Mycapssa ইউরোপীয় ইউনিয়ন - স্লোভাক - EMA (European Medicines Agency)

mycapssa

amryt pharmaceuticals dac - octreotide acetate - akromegália - hypofýzové a hypotalamické hormóny a analógy - mycapssa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.